These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21326256)

  • 1. Pharmacogenomics at the tipping point: challenges and opportunities.
    Roden DM; Tyndale RF
    Clin Pharmacol Ther; 2011 Mar; 89(3):323-7. PubMed ID: 21326256
    [No Abstract]   [Full Text] [Related]  

  • 2. What to expect from the Pharmacogenomics Research Network.
    Long RM; Berg JM
    Clin Pharmacol Ther; 2011 Mar; 89(3):339-41. PubMed ID: 21326260
    [No Abstract]   [Full Text] [Related]  

  • 3. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
    Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
    Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
    [No Abstract]   [Full Text] [Related]  

  • 4. Workshop outcomes report: initiatives to establish a European Network of pharmacogenetics/genomics and progress.
    Maitland-van der Zee AH; Aitchison K; Kirchheiner J;
    Eur J Pharm Sci; 2007 Jul; 31(3-4):151-5. PubMed ID: 17452095
    [No Abstract]   [Full Text] [Related]  

  • 5. The promises of personalized medicine.
    Cascorbi I
    Eur J Clin Pharmacol; 2010 Aug; 66(8):749-54. PubMed ID: 20563567
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
    Sanoudou D
    Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
    [No Abstract]   [Full Text] [Related]  

  • 8. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conference Scene: Pharmacogenomics at the second PharmSciFair 2009: adverse drug reactions and clinical implementation.
    van Schie RM; Cascorbi I; Maitland-van der Zee AH
    Pharmacogenomics; 2009 Sep; 10(9):1389-91. PubMed ID: 19761363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy and pharmacogenomics--hopes and facts].
    Müller-Zellenberg U; Müller M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):45-9. PubMed ID: 15791775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective on the application of pharmacogenomics in the treatment of cancer.
    Wolf R
    Pharmacogenomics; 2009 Apr; 10(4):527-9. PubMed ID: 19374511
    [No Abstract]   [Full Text] [Related]  

  • 12. The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.
    Cavallari LH; Beitelshees AL; Blake KV; Dressler LG; Duarte JD; Elsey A; Eichmeyer JN; Empey PE; Franciosi JP; Hicks JK; Holmes AM; Jeng L; Lee CR; Lima JJ; Limdi NA; Modlin J; Obeng AO; Petry N; Pratt VM; Skaar TC; Tuteja S; Voora D; Wagner M; Weitzel KW; Wilke RA; Peterson JF; Johnson JA
    Clin Transl Sci; 2017 May; 10(3):143-146. PubMed ID: 28294551
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenetics: past, present and future.
    Pirmohamed M
    Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities in pharmacogenomics and therapeutics.
    Kane MD; Summers KH
    J Manag Care Pharm; 2007 Sep; 13(7):607-8. PubMed ID: 17874867
    [No Abstract]   [Full Text] [Related]  

  • 15. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
    O'Donnell PH; Bush A; Spitz J; Danahey K; Saner D; Das S; Cox NJ; Ratain MJ
    Clin Pharmacol Ther; 2012 Oct; 92(4):446-9. PubMed ID: 22929923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conclusion].
    Tillement JP; Goullé JP
    Ann Pharm Fr; 2007 Nov; 65(6):402-3. PubMed ID: 18079672
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?
    Vizirianakis IS
    Pharmacogenomics; 2005 Oct; 6(7):701-11. PubMed ID: 16207147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma pharmacogenomics.
    Hawkins GA; Weiss ST; Bleecker ER
    Immunol Allergy Clin North Am; 2005 Nov; 25(4):723-42. PubMed ID: 16257635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and Challenges in Pharmacogenomics.
    Van Driest SL; Cascorbi I
    Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.